In a study of patients with NAFLD, the presence of IL-17-positive cells was also associated with the presence of portal inflammation and degree of DR [287], suggesting that the Th17 response may be an important mediator of portal-based mechanisms that have been implicated in fibrogenesis [85,88]. Here, IL17A is linked to metabolic dysfunction-associated steatotic liver disease.